Skip to main content

Advertisement

Log in

Recombinant human interleukin-10 in patients with chronic myelomonocytic leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Geissler K (1996) Current status of clinical development of interleukin-10. Curr Opin Hematol 3:203–208

    Article  CAS  PubMed  Google Scholar 

  2. Geissler K, Hinterberger W, Bettelheim P, Haas O, Lechner K (1988) Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res 12:373–377

    Article  CAS  PubMed  Google Scholar 

  3. Geissler K, Ohler L, Födinger M, Virgolini I, Leimer M, Kabrna E, Kollars M, Skoupy S, Bohle B, Rogy M, Lechner K (1996) Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med 184:1377–1384

    Article  CAS  PubMed  Google Scholar 

  4. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220

    Article  Google Scholar 

  5. Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Gangl A, Rutgeerts P, Isaacs K, van Deventer SJ, Koningsberger JC, Cohard M, LeBeaut A, Hanauer SB (2000) Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease. Crohn’s Disease IL-10 Cooperative Study Group. Gastroenterology 119:1461–1472

    Article  CAS  PubMed  Google Scholar 

  6. Keystone E, Wherry J, Grint P (1998) IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin N Am 24:629–639

    Article  CAS  Google Scholar 

  7. Asadullah K, Döcke WD, Ebeling M, Friedrich M, Belbe G, Audring H, Volk HD, Sterry W (1999) Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial. Arch Dermatol 135:187–192

    CAS  PubMed  Google Scholar 

  8. Zuckerman SH, Ackerman SK, Douglas SD (1979) Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology 38:401–411

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Fenaux P, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, Bauters F (1987) Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 65:101–106

    Article  CAS  PubMed  Google Scholar 

  10. Yokozeki H, Takayama K, Ohki O, Satoh T, Umeda T, Katayama I, Nishioka K (1998) Comparative analysis of CD80 and CD86 on human Langerhans cells: expression and function. Arch Dermatol Res 290:547–552

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by AESCA Pharma Ges.m.b.H., Traiskirchen, Austria.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus Geissler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pöchlauer, S., Jäger, E., Jäger, U. et al. Recombinant human interleukin-10 in patients with chronic myelomonocytic leukemia. Ann Hematol 93, 1775–1776 (2014). https://doi.org/10.1007/s00277-014-2012-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2012-5

Keywords

Navigation